[1]
“CLINICAL, SUBCLINICAL, AND FUNGAL ORIGIN FEATURES IN PATIENTS WITH COVID-19 BLOOD FUNGAL INFECTION”, YHCĐ, vol. 67, no. 7, July 2026, doi: 10.52163/yhc.v67i7.5937.